Ivosidenib
C28H22ClF3N6O3 — CID 71657455
View drug profile → ivosidenibData last refreshed: (MolForge compound catalog, from PubChem)
About Ivosidenib
Ivosidenib (PubChem CID 71657455) has the molecular formula C28H22ClF3N6O3 and a molecular weight of 582.97 g/mol. Its IUPAC name is (2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxopyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | Ivosidenib |
|---|---|
| PubChem CID | 71657455 |
| Molecular Formula | C28H22ClF3N6O3 |
| Molecular Weight | 582.97 g/mol |
| Exact Mass | 582.14 |
| IUPAC Name | (2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxopyrrolidine-2-carboxamide |
| SMILES | N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1 |
| InChI | InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25-/m0/s1 |
| InChIKey | WIJZXSAJMHAVGX-DHLKQENFSA-N |
| XLogP | 4.32 |
| TPSA | 119.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 582.97 |
| LogP ≤ 5 | 4.32 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Related Compounds
Frequently Asked Questions
Browse: Molecules: I · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71657455 — identifiers, structure, computed properties (public domain)
- DrugCentral drug card 5292 — approved-drug record (CC BY-SA 4.0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.